89 related articles for article (PubMed ID: 17396728)
41. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
Palavecino EL; Riedel I; Berrios X; Bajaksouzian S; Johnson D; Kaplan E; Jacobs MR
Antimicrob Agents Chemother; 2001 Jan; 45(1):339-41. PubMed ID: 11120993
[TBL] [Abstract][Full Text] [Related]
43. [Antibiotic sensitivity of Streptococcus pyogenes in pediatrics].
Gené A; González-Cuevas A; Juncosa T; Luaces C; Latorre C
Enferm Infecc Microbiol Clin; 1998; 16(6):272-4. PubMed ID: 9763744
[TBL] [Abstract][Full Text] [Related]
44. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
[TBL] [Abstract][Full Text] [Related]
45. Identification and characterization of plasmid-borne erm(T) macrolide resistance in group B and group A Streptococcus.
DiPersio LP; DiPersio JR; Beach JA; Loudon AM; Fuchs AM
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):217-23. PubMed ID: 21899978
[TBL] [Abstract][Full Text] [Related]
46. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
[TBL] [Abstract][Full Text] [Related]
47. Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia.
Zavadska D; Bērziņa D; Drukaļska L; Pugacova N; Miklasevics E; Gardovska D
APMIS; 2010 May; 118(5):366-70. PubMed ID: 20477812
[TBL] [Abstract][Full Text] [Related]
48. Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001.
Katz KC; McGeer AJ; Duncan CL; Ashi-Sulaiman A; Willey BM; Sarabia A; McCann J; Pong-Porter S; Rzayev Y; de Azavedo JS; Low DE
Antimicrob Agents Chemother; 2003 Jul; 47(7):2370-2. PubMed ID: 12821502
[TBL] [Abstract][Full Text] [Related]
49. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.
García-Rey C; Aguilar L; Baquero F; Casal J; Martín JE
J Clin Microbiol; 2002 Aug; 40(8):2959-63. PubMed ID: 12149359
[TBL] [Abstract][Full Text] [Related]
50. [Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption].
De Rosa R; Avolio M; Stano P; Modolo ML; Camporese A
Infez Med; 2009 Jun; 17(2):82-7. PubMed ID: 19602920
[TBL] [Abstract][Full Text] [Related]
51. Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study.
Chazan B; Raz R; Edelstein H; Kennes Y; Gal V; Colodner R
Microb Drug Resist; 2015 Oct; 21(5):551-5. PubMed ID: 26430943
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation.
Baldassarri L; Creti R; Recchia S; Imperi M; Facinelli B; Giovanetti E; Pataracchia M; Alfarone G; Orefici G
J Clin Microbiol; 2006 Aug; 44(8):2721-7. PubMed ID: 16891483
[TBL] [Abstract][Full Text] [Related]
53. Comparative erythromycin and tylosin susceptibility testing of streptococci from bovine mastitis.
Entorf M; Feßler AT; Kaspar H; Kadlec K; Peters T; Schwarz S
Vet Microbiol; 2016 Oct; 194():36-42. PubMed ID: 26732695
[TBL] [Abstract][Full Text] [Related]
54. Arrangement and number of clustered regularly interspaced short palindromic repeat spacers are associated with erythromycin susceptibility in emm12, emm75 and emm92 of group A streptococcus.
Zheng PX; Chiang-Ni C; Wang SY; Tsai PJ; Kuo CF; Chuang WJ; Lin YS; Liu CC; Wu JJ
Clin Microbiol Infect; 2014 Jun; 20(6):516-23. PubMed ID: 24118239
[TBL] [Abstract][Full Text] [Related]
55. Antibacterial resistance in Streptococcus pyogenes (GAS) from healthy carriers and tonsillitis patients and association with antibacterial sale in the Faroe Islands.
Magnussen MD; Gaini S; Gislason H; Kristinsson KG
APMIS; 2016 Apr; 124(4):327-32. PubMed ID: 26833774
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the ability of erythromycin-resistant and -susceptible pharyngeal group A Streptococcus isolates from Spain to enter and persist in human keratinocytes.
Oliver MA; García-Rey C; Bosch R; Albertí S
J Med Microbiol; 2007 Nov; 56(Pt 11):1485-1489. PubMed ID: 17965349
[TBL] [Abstract][Full Text] [Related]
57. Relationship between differences in 16-, 14-, and 15-membered ring macrolides and Streptococcus pyogenes resistance.
Braga PC
Eur J Clin Microbiol Infect Dis; 2002 Feb; 21(2):146-8. PubMed ID: 11939399
[No Abstract] [Full Text] [Related]
58. In vitro activity of antimicrobial agents against streptococcus pyogenes isolated from different regions of Khyber Pakhtun Khwa Pakistan.
Rizwan M; Bakht J; Bacha N; Ahmad B
Pak J Pharm Sci; 2016 Jan; 29(1):59-64. PubMed ID: 26826819
[TBL] [Abstract][Full Text] [Related]
59. [Annual changes in antimicrobial susceptibility and macrolide resistance of Streptococcus pyogenes from 1995 through 2004].
Ogita J; Kurosaki T; Fujisaki K; Makino T; Ishiwada N; Kohno Y
Kansenshogaku Zasshi; 2005 Nov; 79(11):871-6. PubMed ID: 16366358
[TBL] [Abstract][Full Text] [Related]
60. Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains.
Myers AL; Jackson MA; Selvarangan R; Goering RV; Harrison C
Ann Clin Microbiol Antimicrob; 2009 Dec; 8():33. PubMed ID: 19951439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
